By 2030, the proportion of total global deaths due to chronic lifestyle diseases is expected to increase to 70 per cent and the global burden of disease to 56 per cent. The chronic diseases are related to unhealthy diet and nutrition amongst many other factors and present the greatest public health burden, either in terms of direct cost to society and government, or in terms of disability adjusted life years (DALYs). To name few prominent ones -Diabetes, Coronary Heart Diseases(CHD) , Ischemic Brain Diseases, Non Alcoholic Fatty Liver Diseases (NAFLD), Alzheimer’s Disease, Neurodegenerative diseases, Neuropathies, Chronic Kidney Diseases (CKD).

Different Areas of Research

CELAGENEX has developed cutting edge technology platform that combines clinically proven unique biological metabolites (compounds) & bioavailability enhancers to regulate cellular metabolism.

The company has protected the discovery and application of its portfolio through extensive IP that includes thirteen issued and or filed and allowed to date with corresponding patents pending globally.